Questions and answers: Immuniser Lyon

Dr Anne Sophie Ronnaux-Baron

Description of the initiative

Q1: How did this initiative start?  What were the needs it addressed?

A: The initiative began in 2015, due to the realization that some vaccination programs were being challenged and that there was an increase in mistrust in France.

To meet these concerns, the main objective of the Immuniser Lyon program was to raise awareness among stakeholders and the general population about infectious disease prevention and lifelong immunization. It was the first time a project was based on the initiative and actions of an independent public-private collective in the metropolitan area of Lyon.

Q2: Can you describe how civil society was included in your project?

A: The Immuniser Lyon collective relays to be present and to answer the questions of the general public during numerous events involving people of all ages. Patient associations and health networks are partners in the initiative.

Q3: Why do you think it was important to include civil society in your project?

A: In order to answer a need for information. Indeed, many studies confirm that the French population has many questions to ask about vaccination.

The association of more than 35 partners marks an institutional commitment, reinforces the importance of defending vaccination and organizing a reference network to find reliable, verified and referenced information.

Q4: What was found to influence the attitudes / beliefs of the population towards vaccination?

A: The vast majority of French people are hesitant regarding vaccination because of conflicting messages in the press and the media. Being able to talk directly with them, listen to them and provide them a platform for voicing their concerns and questions is sufficient to provide reassurance.

Q5: Are adults and older people also concerned by vaccines?

A: Of course, vaccination concerns all citizens, regardless of age, for them or their families. Immunization protects against infectious diseases at all ages.

Q6: What trustworthy information sources for websites would you recommend?

A: Immuniser Lyon recommends all websites of health authorities:, Public Health France, ...

Q7: What is the main message Immuniser Lyon wants to communicate?

A: Immuniser Lyon invites health professionals and the general public to check their vaccination status, with the slogan: for us it's done!

Q8: Was there an evaluation of the project conducted? If yes, what were the results?

A: Several qualitative and quantitative evaluations are ongoing.

Q9: Do you think your project could be implemented in other regions / countries / communities? Has this already been the case?

A: Yes this is already the case in Nice with Vacci 'Nice, and other projects are underway in Montpellier, Bordeaux and Nantes.

Q10: Please feel free to add any other comments you might have.

A: You will find on our website, the news from the project partners and up-to-date vaccination recommendations. We remain at your disposal for further information.

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence